Author:
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Central Tuberculosis Division, National Tuberculosis Elimination Programme, 2021. Guidelines for Programmatic Management of Drug Resistant Tuberculosis in India. Available at: https://tbcindia.mohfw.gov.in/wp-content/uploads/2023/05/8368587497Guidelines-for-PMDT-in-India-1.pdf. Accessed October 13, 2024.
-
2.
Calnan CH, Fregert S, Magnusson B, 1976. The International Contact Dermatitis Research Group. Cutis 18: 708–710.
-
3.
Agrebi S, Saad SB, Habouria C, Daghfous H, Tritar F, 2017. Tolerance and side effects of second line anti tubercular drugs. Eur Respi J 50: PA2705.
-
4.
Kulthanan K, Chularojanamontri L, Manapajon A, Dhana N, Jongjarearnprasert K, 2011. Cutaneous adverse reactions to fluoroquinolones. Dermatitis 22: 155–160.
-
5.
Kim H, Bang ES, Lim SK, Lee JM, 2016. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: Case report. Int J Clin Pharmacol Ther 54: 808–815.
-
6.
Shim JH, Kim TY, Kim HO, Kim CW, 1995. Cycloserine-induced lichenoid drug eruption. Dermatology 191: 142–144.
-
7.
Shanmukhappa SC, John W, Kevalramani V, Lokeshwaran S, Furtado S, Nosenoor M, 2024. Antitubercular drug-induced lichen planus: A case study with a mini literature review. J Family Med Prim Care 13: 438–443.
-
8.
Bajoriuniene I, Musteikiene G, Ramonaite A, Sitkauskiene B, 2021. DiHS/DRESS syndrome induced by second-line treatment for tuberculosis and Epstein-Barr virus. Cent Eur J Immunol 46: 401–404.
-
9.
Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A, 2010. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62: 47–53.
-
10.
Grandhe NP, Kaur I, Parsad D, Dogra S, 2004. Role of patch testing in antimicrobial drug eruptions. Contact Dermatitis 50: 259–261.
-
11.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D, 2023. Drug hypersensitivity in drug-resistant tuberculosis. World Allergy Organ J 16: 100778.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1471 | 1471 | 106 |
| Full Text Views | 21 | 21 | 12 |
| PDF Downloads | 25 | 25 | 14 |
Patch Test-Positive Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome Due to Cycloserine in Multidrug-Resistant Tuberculosis: A Case Report with a Review of the Literature
Priyadharshini Basavarajpura Vijay
Priyadharshini Basavarajpura Vijay
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
Search for other papers by Priyadharshini Basavarajpura Vijay in
Current site
Google Scholar
PubMed
Search for other papers by Priyadharshini Basavarajpura Vijay in
Current site
Google Scholar
PubMed
Mrinal Kanti Das
Mrinal Kanti Das
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
Search for other papers by Mrinal Kanti Das in
Current site
Google Scholar
PubMed
Search for other papers by Mrinal Kanti Das in
Current site
Google Scholar
PubMed
Amar Bahadur
Amar Bahadur
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
Search for other papers by Amar Bahadur in
Current site
Google Scholar
PubMed
Search for other papers by Amar Bahadur in
Current site
Google Scholar
PubMed
Chirantan Shivaji
Chirantan Shivaji
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
Search for other papers by Chirantan Shivaji in
Current site
Google Scholar
PubMed
Search for other papers by Chirantan Shivaji in
Current site
Google Scholar
PubMed
Tanvi Dev
ivnat2008@gmail.com
Tanvi Dev
Department of Dermatology, Maulana Azad Medical College, New Delhi, India
Search for other papers by Tanvi Dev in
Current site
Google Scholar
PubMed
Search for other papers by Tanvi Dev in
Current site
Google Scholar
PubMed
ABSTRACT.
Antitubercular treatment (ATT) is associated with multiple cutaneous adverse drug reactions. Second-line ATT is also associated with numerous adverse reactions; however, cutaneous reactions are under-reported. Oral drug provocation (ODP) in multidrug-resistant tuberculosis is challenging because of the paucity of time and the risk of developing secondary drug resistance in the case of interrupted medication. In this paper, we report a case of drug reaction with eosinophilia and systemic symptoms caused by cycloserine in an 18-year-old girl, which was confirmed with ODP and a patch test.
Author Notes
Current contact information: Priyadarshini Basavarajpura Vijay, Mrinal Kanti Das, Amar Bahadur, Chirantan Shivaji, and Tanvi Dev, Maulana Azad Medical College, New Delhi, India, E-mails: priyarakesh95@gmail.com, mrinalkgt@gmail.com, amar921198@gmail.com, chiranthan2013s@gmail.com, and ivnat2008@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Central Tuberculosis Division, National Tuberculosis Elimination Programme, 2021. Guidelines for Programmatic Management of Drug Resistant Tuberculosis in India. Available at: https://tbcindia.mohfw.gov.in/wp-content/uploads/2023/05/8368587497Guidelines-for-PMDT-in-India-1.pdf. Accessed October 13, 2024.
-
2.
Calnan CH, Fregert S, Magnusson B, 1976. The International Contact Dermatitis Research Group. Cutis 18: 708–710.
-
3.
Agrebi S, Saad SB, Habouria C, Daghfous H, Tritar F, 2017. Tolerance and side effects of second line anti tubercular drugs. Eur Respi J 50: PA2705.
-
4.
Kulthanan K, Chularojanamontri L, Manapajon A, Dhana N, Jongjarearnprasert K, 2011. Cutaneous adverse reactions to fluoroquinolones. Dermatitis 22: 155–160.
-
5.
Kim H, Bang ES, Lim SK, Lee JM, 2016. DRESS syndrome and acute generalized exanthematous pustulosis induced by antituberculosis medications and moxifloxacin: Case report. Int J Clin Pharmacol Ther 54: 808–815.
-
6.
Shim JH, Kim TY, Kim HO, Kim CW, 1995. Cycloserine-induced lichenoid drug eruption. Dermatology 191: 142–144.
-
7.
Shanmukhappa SC, John W, Kevalramani V, Lokeshwaran S, Furtado S, Nosenoor M, 2024. Antitubercular drug-induced lichen planus: A case study with a mini literature review. J Family Med Prim Care 13: 438–443.
-
8.
Bajoriuniene I, Musteikiene G, Ramonaite A, Sitkauskiene B, 2021. DiHS/DRESS syndrome induced by second-line treatment for tuberculosis and Epstein-Barr virus. Cent Eur J Immunol 46: 401–404.
-
9.
Santiago F, Gonçalo M, Vieira R, Coelho S, Figueiredo A, 2010. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis 62: 47–53.
-
10.
Grandhe NP, Kaur I, Parsad D, Dogra S, 2004. Role of patch testing in antimicrobial drug eruptions. Contact Dermatitis 50: 259–261.
-
11.
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, Mersin SS, Örçen C, Yakut T, Yavuz D, 2023. Drug hypersensitivity in drug-resistant tuberculosis. World Allergy Organ J 16: 100778.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1471 | 1471 | 106 |
| Full Text Views | 21 | 21 | 12 |
| PDF Downloads | 25 | 25 | 14 |